When discussing value in oncology, the outcomes that matter are those that are important to the patient, said Stuart Goldberg, MD, chief medical officer, Cancer Outcomes Tracking and Analysis, John Theurer Cancer Center. He also discussed how the use of data to stratify patients is important for providing value-based cancer care.
When discussing value in oncology, the outcomes that matter are those that are important to the patient, said Stuart Goldberg, MD, chief medical officer, Cancer Outcomes Tracking and Analysis, John Theurer Cancer Center. He also discussed how the use of data to stratify patients is important for providing value-based cancer care.
Transcript (slightly modified)
What key factors can ensure that cancer programs are more patient-centered?
Value is the new word in oncology and in payment models, and we define value as outcomes divided by cost. That’s pretty easy, but the question is how do we define outcomes? In patient-centric models, we need to remember that the outcomes are those outcomes that are important to the patient. In cancer we may think of overall survival, but how do we account for the patient who chooses hospice or palliative care? We need to be able to think about what from the patient’s standpoint is important to them and then put that into our equation.
Data analytics and outcomes tracking can inform and improve care delivery. What has been the experience at the John Theurer Cancer Center?
Data will be key to understanding any value-based program. I actually run a data company that analyzes outcomes and costs for patients with cancer. We’ve focused on stratifying patients, because cancer isn’t 1 disease. Breast cancer is not just breast cancer, there’s HER2/neu positive and HER2/neu negative. There’s ER positive and ER negative. And part of the problem with analyzing oncology data has been the complexity. So we’ve developed an entire new lexicon, a new classification system, to stratify patients. And now we have to even think about the comorbidities like diabetes or heart disease, which are also going to affect the outcomes and the cost.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More